BACKGROUND: Kaposi sarcoma-associated herpesvirus (KSHV) infection is endemic among adult populations in Africa. A prevailing view is that childhood transmission is primarily responsible for the high seroprevalence of KSHV among adults that is observed throughout the continent. However, few studies have directly examined children, particularly in locations where KS is not commonly endemic. METHODS: Participants were children aged 1.5-8.9 years, including 427 children from a population-based sample in South Africa, 422 from a population-based sample in Uganda, and 567 from a clinic-based sample in Uganda. All serum specimens were tested by the same laboratory for KSHV antibodies with use of 2 enzyme immunoassays (against K8.1 and ORF65) and 1 immunofluorescence assay. RESULTS: KSHV seroprevalence was 7.5%-9.0% among South African children and was not associated with age. In contrast, in the Ugandan population-based sample, KSHV seroprevalence increased from 10% among 2-year-old children to 30.6% among 8-year-old children (P(trend) < .001). In the Ugandan clinic-based sample, seroprevalence increased from 9.3% among 2-year-old children to 36.4% among 8-year-old children (P(trend) < .001). CONCLUSION: Two distinct relationships between age and KSHV infection among children imply that KSHV transmission among children is not uniform throughout Africa and is therefore not always responsible for the high seroprevalence observed in adults. There are at least 2 patterns of KSHV transmission in Africa.
BACKGROUND:Kaposi sarcoma-associated herpesvirus (KSHV) infection is endemic among adult populations in Africa. A prevailing view is that childhood transmission is primarily responsible for the high seroprevalence of KSHV among adults that is observed throughout the continent. However, few studies have directly examined children, particularly in locations where KS is not commonly endemic. METHODS:Participants were children aged 1.5-8.9 years, including 427 children from a population-based sample in South Africa, 422 from a population-based sample in Uganda, and 567 from a clinic-based sample in Uganda. All serum specimens were tested by the same laboratory for KSHV antibodies with use of 2 enzyme immunoassays (against K8.1 and ORF65) and 1 immunofluorescence assay. RESULTS:KSHV seroprevalence was 7.5%-9.0% among South African children and was not associated with age. In contrast, in the Ugandan population-based sample, KSHV seroprevalence increased from 10% among 2-year-old children to 30.6% among 8-year-old children (P(trend) < .001). In the Ugandan clinic-based sample, seroprevalence increased from 9.3% among 2-year-old children to 36.4% among 8-year-old children (P(trend) < .001). CONCLUSION: Two distinct relationships between age and KSHV infection among children imply that KSHV transmission among children is not uniform throughout Africa and is therefore not always responsible for the high seroprevalence observed in adults. There are at least 2 patterns of KSHV transmission in Africa.
Authors: H Mantina; C Kankasa; W Klaskala; B Brayfield; J Campbell; Q Du; G Bhat; F Kasolo; C Mitchell; C Wood Journal: Int J Cancer Date: 2001-12-01 Impact factor: 7.396
Authors: Dorothy N Kakoola; Julie Sheldon; Naomi Byabazaire; Rory J Bowden; Edward Katongole-Mbidde; Thomas F Schulz; Andrew J Davison Journal: J Gen Virol Date: 2001-10 Impact factor: 3.891
Authors: Jared M Baeten; Bhavna H Chohan; Ludo Lavreys; Joel P Rakwar; Rhoda Ashley; Barbra A Richardson; Kishorchandra Mandaliya; Job J Bwayo; Joan K Kreiss Journal: AIDS Date: 2002-10-18 Impact factor: 4.177
Authors: Khaled R Alkharsah; Martin Dedicoat; Rainer Blasczyk; Robert Newton; Thomas F Schulz Journal: J Infect Dis Date: 2007-02-05 Impact factor: 5.226
Authors: Sam M Mbulaiteye; Ruth M Pfeiffer; Denise Whitby; Glen R Brubaker; John Shao; Robert J Biggar Journal: J Infect Dis Date: 2003-06-01 Impact factor: 5.226
Authors: D Serraino; L Toma; M Andreoni; S Buttò; O Tchangmena; L Sarmati; P Monini; S Franceschi; B Ensoli; G Rezza Journal: Eur J Epidemiol Date: 2001 Impact factor: 8.082
Authors: Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin Journal: J Infect Dis Date: 2011-01-26 Impact factor: 5.226
Authors: Veenu Minhas; Kay L Crabtree; Ann Chao; Janet M Wojcicki; Adrian M Sifuniso; Catherine Nkonde; Chipepo Kankasa; Charles D Mitchell; Charles Wood Journal: Am J Epidemiol Date: 2011-03-28 Impact factor: 4.897
Authors: Kay L Crabtree; Janet M Wojcicki; Veenu Minhas; David R Smith; Chipepo Kankasa; Charles D Mitchell; Charles Wood Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-12-02 Impact factor: 4.254